TY  - GEN
AU  - Ali,H R
AU  - Dariush,A
AU  - Thomas,J
AU  - Provenzano,E
AU  - Dunn,J
AU  - Hiller,L
AU  - Vallier,A-L
AU  - Abraham,J
AU  - Piper,T
AU  - Bartlett,J M S
AU  - Cameron,D A
AU  - Hayward,L
AU  - Brenton,J D
AU  - Pharoah,P D P
AU  - Irwin,M J
AU  - Walton,N A
AU  - Earl,H M
AU  - Caldas,C
TI  - Lymphocyte density determined by computational pathology validated as a predictor of response to neoadjuvant chemotherapy in breast cancer: secondary analysis of the ARTemis trial
SN  - 1569-8041
PY  - 2018///0507
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Bevacizumab
KW  - Breast Neoplasms
KW  - drug therapy
KW  - Computational Biology
KW  - Cyclophosphamide
KW  - Epirubicin
KW  - Female
KW  - Fluorouracil
KW  - Humans
KW  - Lymphocyte Count
KW  - Lymphocytes
KW  - pathology
KW  - Lymphocytes, Tumor-Infiltrating
KW  - Neoadjuvant Therapy
KW  - Polymerase Chain Reaction
KW  - Remission Induction
N1  - Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
UR  - https://doi.org/10.1093/annonc/mdx266
ER  -